Portfolio Active

Company: Atro Medical - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2017
Status: Active

Nijmegen based Radboudumc spin-off Atro Medical develops an anatomically shaped polymer based meniscus implant, the Trammpolin, with the aim of restoring the protective function of the meniscus by acting as a joint spacer.

Company: MILabs - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

MILabs is a company based in Utrecht, that develops and sells state of the art molecular imaging devices, for preclinical use. In addition, MILabs is developing a clinical SPECT scanner that will have unprecedented imaging capabilities, allowing doctors to make images well beyond what they can image today.

Company: Indigo Diabetes - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

Indigo Diabetes is a Belgian startup developing novel glucose sensor technology based on photonics, thus avoiding the need for frequent calibration

Company: NutriLeads - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2015
Status: Active

Wageningen based company active in the field of medical nutrition and functional foods. Currently develops a food ingredient with immune system enhancing properties to help combat infections.

Company: Encare Biotech - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2014
Status: Active

Encare Biotech is a spin-off of Utrecht UMC, dedicated to develop antibody therapeutics to prevent chronic heart failure as a consequence of a myocardial infarction.

Company: Mellon Medical B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2013
Status: Active

Mellon Medical B.V. is a Dutch specialist medical technology company that develops and commercializes innovative surgical instruments to allow for single-handed stitching.

Company: Cristal Therapeutics - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2012
Status: Active

Cristal Therapeutics (formerly known as Cristal Delivery) is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies, registered as CriPec®.  Cristal Delivery’s mission is optimise the therapeutic performance of drugs and thereby improve patient care.

Company: TheraSolve N.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2011
Status: Active

TheraSolve develops a skin patch technology (embedded electronics) to improve drug treatment compliance.

Company: Fabpulous B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2009
Status: Active

Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.

Company: Cavadis B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2009
Status: Active

Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.

Company: Hemics B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2011
Status: Active

Hemics is a medical technology company (Philips spin-out), developing an imaging apparatus to measure and monitor rheumatoid arthritis disease activity in the joints of the hands.

Company: NightBalance B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2011
Status: Active

NightBalance is a medtech company developing and commercializing a patient-friendly device to treat positional sleep apnea.